Absence of QTc prolongation in a thorough QT study with imeglimin, a first in class oral agent for type 2 diabetes mellitus
Julie Dubourg, Sandrine Perrimond-Dauchy, Mathieu Felices, Sébastien Bolze, Pascal Voiriot, Pascale Fouqueray
Topics & Concepts
QT intervalMedicineProlongationDiabetes mellitusType 2 Diabetes MellitusInternal medicinePharmacologyLong QT syndromeCardiologyEndocrinologyCardiac electrophysiology and arrhythmiasDiabetes Treatment and ManagementDiabetes Management and Research